NIHR Global Health Research Unit on Respiratory Health (RESPIRE-2) Vision: To improve quality of life and reduce the number of deaths from respiratory disorders by expanding research infrastructure, capacity and capability to conduct outstanding applied respiratory research, creating an Asian respiratory translational research network of excellence.

The aim of RESPIRE (Phase 2) is to deliver low-cost, scalable policy and clinical interventions which address locally-identified problems. We aim to act as a source of expertise and resource to policymakers, ministries of health, health workers and communities in our 7 ODA eligible partner countries across Asia (Pakistan, Sri Lanka, Bangladesh, India, Indonesia, Bhutan, Malaysia). Our Unit aims to build on the capacity development, research outputs and relationships from RESPIRE (Phase 1: 2017-2022) to contribute to improving global respiratory health. In so doing, RESPIRE aims to disseminate knowledge on existing evidence-based interventions that can be adapted for Asian settings, promote innovation to generate and evaluate new interventions and approaches, provide technical support to implementation of respiratory health programmes and identify/develop and promote innovative new approaches and delivery mechanisms. 

Our overarching objectives include: Building research and research management capacity in our Asian partner countries; ensuring research is driven by the needs/priorities of LMIC populations and is based on equitable/respectful partnerships; strengthening capacity to translate research findings into impact; engaging stakeholders, involving patients and communities, where appropriate, as key partners at all stages; and considering the context of COVID-19, where relevant. Short-term (year 1):
• Promote respectful and equitable partnerships and shared values on research governance and ethical conduct of research across RESPIRE; 
• Establish RESPIRE governance and administrative arrangements (including due diligence, research contracts and financial reporting), ensuring deliverables and reports are completed on time; 
• Set up and commence agreed programmes of work (including submitting governance (sponsorship) and ethics applications where needed) within the Unit research programmes and platforms.

Medium-term (years 2-3):
• Maintain close monitoring of and support to research programmes giving assistance in problem solving and taking risk mitigation action, where necessary; 
• Ensure translational platforms are having an impact on the work of the Unit in the areas of stakeholder engagement, education/capacity building, data science and digital health and innovation; 
• Ensure the Translational Platforms Coordination Group is working effectively to integrate Unit outputs and these are being used effectively to have an impact on respiratory health policy and practice in partner countries; 
• Ensure study findings are communicated to local communities and consultation takes place to co-develop plans for follow on actions; 
• Submit collaborative follow-on grants to extend work and tackle gaps that have been identified; 
• Develop plans for longer term sustainability.

Long-term (years 3-4):
• Ensure the Translational Platforms Coordination Group is maximising the local, regional and global impact from the new knowledge and experience generated by RESPIRE; 
• Communicate RESPIRE-2 findings to policymakers, health professionals and communities through publication in respected journals, presentation at national/regional and global meetings and publication in social media; 
• Submit collaborative follow-on grants to sustain RESPIRE activities into the future.